S. Richter

Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin

C. Ulrich, H. Brenner, J. Chang-Claude, 2014, Pharmacogenetics and genomics.

Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.

A. Benz, K. Engels, B. Kronenberger, 2012, Neoplasia.

Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer

N. Habermann, C. Ulrich, H. Brenner, 2015, The Pharmacogenomics Journal.

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.

Eva Herrmann, Christoph Sarrazin, Stefan Zeuzem, 2009, Radiology.

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.

M. Friedrich-Rust, C. Dietrich, E. Herrmann, 2009, Radiology.

633 EVALUATION OF A PREDICTIVE MODEL OF INDIVIDUAL CHANCE FOR SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN

E. Herrmann, S. Mauss, D. Hueppe, 2009 .